188 related articles for article (PubMed ID: 6834271)
1. Avoidance of "first-pass" elimination of rectally administered lidocaine in relation to the site of absorption in rats.
de Leede LG; de Boer AG; Roozen CP; Breimer DD
J Pharmacol Exp Ther; 1983 Apr; 225(1):181-5. PubMed ID: 6834271
[TBL] [Abstract][Full Text] [Related]
2. Rectal, oral and I.A. administration of etomidate to rats: significant avoidance of hepatic first-pass elimination following rectal administration.
de Boer AG; Breimer DD
Arch Int Pharmacodyn Ther; 1984 Aug; 270(2):180-91. PubMed ID: 6548357
[TBL] [Abstract][Full Text] [Related]
3. Rectal bioavailability of lidocaine in the dog: evaluation of first-pass elimination.
Ritschel WA; Grummich KW; Hussain AS; Denson DD; Ritschel BE
Methods Find Exp Clin Pharmacol; 1987 Aug; 9(8):497-502. PubMed ID: 3695734
[TBL] [Abstract][Full Text] [Related]
4. Rectal bioavailability of lidocaine in man: partial avoidance of "first-pass" metabolism.
de Boer AG; Breimer DD; Mattie H; Pronk J; Gubbens-Stibbe JM
Clin Pharmacol Ther; 1979 Dec; 26(6):701-9. PubMed ID: 498711
[TBL] [Abstract][Full Text] [Related]
5. Avoidance of "first-pass" elimination of rectally administered propranolol in relation to the site of absorption in rats.
de Leede LG; de Boer AG; Havermans JP; Breimer DD
Pharm Res; 1984 Jul; 1(4):164-8. PubMed ID: 24277285
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of aminomethylpropanol in rats following oral and a novel dermal study design.
Saghir SA; Clark AJ; McClymont EL; Staley JL
Food Chem Toxicol; 2008 Feb; 46(2):678-87. PubMed ID: 17961896
[TBL] [Abstract][Full Text] [Related]
7. Site specific rectal drug administration in man with an osmotic system: influence on "first-pass" elimination of lidocaine.
de Leede LG; de Boer AG; Feijen CD; Breimer DD
Pharm Res; 1984 May; 1(3):129-34. PubMed ID: 24277250
[TBL] [Abstract][Full Text] [Related]
8. Hepatic and intestinal first-pass effects of oltipraz in rats.
Bae SK; Kim JW; Kim YH; Kim YG; Kim SG; Lee MG
Biopharm Drug Dispos; 2005 May; 26(4):129-34. PubMed ID: 15744718
[TBL] [Abstract][Full Text] [Related]
9. Absorption, distribution and excretion of [14C]E-4716 after single-dose administration in rats and dogs.
Serafini MT; Puig S; Pretel MJ; García A; Martínez L
Methods Find Exp Clin Pharmacol; 1997; 19(6):407-15. PubMed ID: 9385590
[TBL] [Abstract][Full Text] [Related]
10. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
[TBL] [Abstract][Full Text] [Related]
11. Single dose pharmacokinetics and bioavailability of glucosamine in the rat.
Aghazadeh-Habashi A; Sattari S; Pasutto F; Jamali F
J Pharm Pharm Sci; 2002; 5(2):181-4. PubMed ID: 12207871
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of pharmacokinetics, brain levels and protein binding of centpropazine in rats.
Bhattaram VA; Paliwal JK; Gupta RC
Biopharm Drug Dispos; 2004 Mar; 25(2):69-75. PubMed ID: 14872554
[TBL] [Abstract][Full Text] [Related]
13. Hepatic and intestinal first-pass effects of a new hepatoprotective agent, YH439, in rats.
Kim J; Han KS; Lee JW; Lee MG
Res Commun Mol Pathol Pharmacol; 1998 Nov; 102(2):125-36. PubMed ID: 10100504
[TBL] [Abstract][Full Text] [Related]
14. Absorption and disposition of epithiosteroids in rats (1): Route of administration and plasma levels of epitiostanol.
Ichihashi T; Kinoshita H; Shimamura K; Yamada H
Xenobiotica; 1991 Jul; 21(7):865-72. PubMed ID: 1776262
[TBL] [Abstract][Full Text] [Related]
15. Studies on the first-pass metabolism of ebastine in rats.
Fujii T; Matsumoto S; Hatoyama T; Miyazaki H
Arzneimittelforschung; 1997 Aug; 47(8):949-53. PubMed ID: 9296281
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 1st communication: absorption, concentrations in plasma, metabolism, and excretion after single administration to rats and dogs.
Boberg M; Ahr HJ; Beckermann B; Bühner K; Siefert HM; Steinke W; Wünsche C; Hirayama M
Arzneimittelforschung; 1997 Aug; 47(8):928-38. PubMed ID: 9296279
[TBL] [Abstract][Full Text] [Related]
17. Absorption and enterohepatic circulation of baicalin in rats.
Xing J; Chen X; Zhong D
Life Sci; 2005 Nov; 78(2):140-6. PubMed ID: 16107266
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 3rd Communication: suppositories.
Lintz W; Barth H; Osterloh G; Schmidt-Böthelt E
Arzneimittelforschung; 1998 Sep; 48(9):889-99. PubMed ID: 9793614
[TBL] [Abstract][Full Text] [Related]
19. Absorption and disposition of epithiosteroids in rats (2): Avoidance of first-pass metabolism of mepitiostane by lymphatic absorption.
Ichihashi T; Kinoshita H; Yamada H
Xenobiotica; 1991 Jul; 21(7):873-80. PubMed ID: 1776263
[TBL] [Abstract][Full Text] [Related]
20. Oral and topical absorption, disposition kinetics, and the metabolic fate of trans-methyl styryl ketone in the male Fischer 344 rat.
Sauer JM; Smith RL; Bao J; Kattnig MJ; Kuester RK; McClure TD; Mayersohn M; Sipes IG
Drug Metab Dispos; 1997 Jun; 25(6):732-9. PubMed ID: 9193875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
